Immunomedics, Inc. (IMMU) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Research and development: 129.19K
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Research and development: 129.19K
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Immunomedics, Inc. (NASDAQ: IMMU) reported Q4 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $1.2 million.
For earnings history and earnings-related data on Immunomedics, Inc. (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Super Micro Computer (SMCI) Falls 6%
- P&G lifts annual profit forecast on strong US consumer demand, easing costs
- Safe & Green (SGBX) Provides Update on Audit and Planned 10-K Filing
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
